HCA Healthcare (NYSE:HCA – Get Rating) had its target price increased by Credit Suisse Group from $282.00 to $311.00 in a report published on Monday morning, The Fly reports. A number of other equities research analysts also recently issued reports on the stock. Loop Capital increased their price objective on shares of HCA Healthcare from […]
HCA Healthcare, Inc. (NYSE:HCA – Get Rating) – SVB Leerink issued their Q1 2025 earnings per share estimates for shares of HCA Healthcare in a report issued on Monday, April 24th. SVB Leerink analyst W. Mayo anticipates that the company will earn $5.67 per share for the quarter. The consensus estimate for HCA Healthcare’s current […]
HCA Healthcare (NYSE:HCA – Get Rating) had its price objective raised by stock analysts at Royal Bank of Canada from $283.00 to $315.00 in a report issued on Monday, The Fly reports. Royal Bank of Canada’s target price points to a potential upside of 11.71% from the company’s previous close. A number of other brokerages […]
HCA Healthcare (NYSE:HCA – Get Rating) had its price objective raised by stock analysts at Royal Bank of Canada from $283.00 to $315.00 in a report released on Monday, The Fly reports. Royal Bank of Canada’s price target indicates a potential upside of 11.71% from the company’s current price. Other analysts also recently issued reports […]
Convergence Investment Partners LLC lowered its position in HCA Healthcare, Inc. (NYSE:HCA – Get Rating) by 11.8% during the 4th quarter, according to its most recent disclosure with the Securities and Exchange Commission. The firm owned 960 shares of the company’s stock after selling 129 shares during the quarter. Convergence Investment Partners LLC’s holdings in […]